{"$id":"https://anubis.scilifelab.se/api/calls/open","timestamp":"2026-08-18T17:57:16.129Z","title":"All open calls.","calls":[{"identifier":"DDLS_RS_courses_2026","title":"Call for DDLS Research School Courses to be given 2027","href":"https://anubis.scilifelab.se/call/DDLS_RS_courses_2026","opens":"2026-05-07T06:00:00.000Z","closes":"2026-08-19T12:00:00.000Z","description":"The DDLS Research School (RS) opens a call for courses in topics of relevance for data-driven life science research. The call is open to any researcher with an affiliation to a Swedish university. Here we ask for courses to be given in 2027.  \r\n\r\n\r\n","labels":[]},{"identifier":"Call_DDD_May2026","title":"Call for new drug discovery projects at SciLifeLab DDD 2026","href":"https://anubis.scilifelab.se/call/Call_DDD_May2026","opens":"2026-05-15T06:00:00.000Z","closes":"2026-08-24T21:59:00.000Z","description":"The Drug Discovery and Development (DDD) Platform at SciLifeLab supports academic drug discovery project with expertise and technical capabilities. We have, for example, platforms to develop small molecule drugs, therapeutic antibodies, oligonucleotide therapeutics, proximity-inducing agents such as bispecific antibodies and PROTACs. The DDD offer includes full infrastructure support, a competitive/generous cost model, and full retention of ownership for the project proposer (the academic PI).\r\n\r\nThe DDD Platform is looking for new project proposals for drug discovery. **All therapeutic modalities** outlined above are of interest but we especially encourage proposals based on **small molecules** to apply in the present call. DDD supports a project portfolio consisting of about 20 programs and we foresee a need to replenish our portfolio with 3-5 new programs this year. We are interested in programs with defined targets for diseases with medical needs. Therapeutic ideas based on technologies that can be extended to other targets and/or other indications are of special interest, i.e. therapeutic platform technologies, as are projects to develop therapeutic molecules with innovative mode-of-actions (e.g., targeted delivery or new modes-of-action for antisense oligonucleotides, small molecules, antibodies and/or proximity-inducers).\r\n\r\nNote that limited projects for selections in phage display libraries for antibodies, selections in DNA encoded chemical libraries for small molecules or limited screening for antisense or siRNA molecules can be considered. \r\n\r\nA description of new modalities in drug discovery research can be found here: [https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00582](https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00582)\r\n\r\nIf you have questions about the call please contact DDD by email (dddprojectproposal@scilifelab.se). For information about the Drug Discovery and Development platform please visit our website [https://www.scilifelab.se/units/ddd-platform/](https://www.scilifelab.se/units/ddd-platform/). This call is open for scientists with a doctoral degree employed at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed.\r\n","labels":[]},{"identifier":"PALS_4_2026","title":"PALS call no 4 (2026)","href":"https://anubis.scilifelab.se/call/PALS_4_2026","opens":"2026-05-29T07:00:00.000Z","closes":"2026-09-01T10:00:00.000Z","description":"Aim and scope \r\nThis call is part of the PALS initiative, supported by the Knut and Alice Wallenberg Foundation.  \r\nWith this call, PALS wants to support and promote scientific interactions between fellows from the different PALS programs and/or from different centers. The supported collaborations can involve research or other related activities in all areas of the different programs such as molecular medicine or different areas of life science and can be technology-driven or data-driven projects from fundamental, preclinical, translational, and clinical scientists.  \r\nThe supported collaborations, either a research project or an event in Sweden, organized and coordinated jointly by the fellows, should: \r\n- add novelty\r\n- be innovative and cross-disciplinary \r\n- aim for either or several of the following: technology development, knowledge transfer, data transfer\r\nThis annual call will support collaborations with funding in a span between 100.000 and 500.000 SEK (including indirect costs), the total annual sum awarded is 2.7 MSEK. KAW only reimburses operating costs (“drift”) and overhead (if any, and max 20%).\r\n\r\nWho can apply? \r\nThe call is open for fellows, associated fellows and fellow alumni in the PALS community (WCMM, DDLS, SciLifeLab, MIMS, WIFORCE) and can also involve a collaborator as co-applicant from SciLifeLab's infrastructure. \r\nThe proposed project needs to involve two or three applicants, representing either at least two different PALS programs (DDLS, SciLifeLab, WCMM, MIMS or WIFORCE) or SciLifeLab infrastructure, or at least two different universities or organisations connected to the programs (KTH, LU, GU, UMU, LIU, KI, UU, SU, Chalmers, NRM and SLU). Priority will be given to new collaborations (as compared to already existing).\r\nEach applicant needs to be actively involved in the project, the main applicant is the administrative person who is responsible for submitting the application and communication with co-applicants. The funding will be paid out to each project partner (applicant and co-applicant/s) separately, the funding can only be paid to an organisation connected to the program via requisition. An applicant can be part of max. 2 applications (main or co-applicant).  \r\n\r\nProject period \r\nThe project period is January 1st-December 31st, 2027, the reporting and requisition is made in February 2028. Reporting templates will be provided.  \r\nSelected projects are expected to be presented at the PALS meeting during the project period (annual PALS meeting 2027), and the project results at the PALS meeting after the project period, in 2028. Information about the funded projects will be published at palsnetwork.se.\r\n\r\nEvaluation criteria\r\nApplications will be evaluated according to the assessment of the combination of the following criteria: \r\n- Scientific quality and potential for novelty and originality  \r\n- Multi-disciplinary or translational approach  \r\n- Potential future or long-term impact  \r\n- Potential synergies in the planned collaboration \r\n- Merit of ideas and alignment with the goals of PALS \r\n\r\nFor events we also consider: \r\n- Clear impact for the PALS community  \r\n- Clear aim of the event\r\n\r\nWe will also consider: \r\n- If the project establishes a new collaboration\r\n- If the project plan aligns with the scope of the call with regards to project time (12 months) and requested funding\r\n- Open science and data sharing aspects \r\n- Industrial and societal relevance \r\n- Complementarity of the applications (for example, gender balance, career stage, geographical distribution and project topic)\r\n- Clear and active involvement of all partners\r\n- When submitting a joint application with a co-applicant from SciLifeLab infrastructure is submitted, the co-applicant must be actively involved in the research project. It is not sufficient for an individual fellow to apply only for access to an infrastructure service ( as a user). \r\n\r\nApplicants should keep in mind that, due to the broad range of research areas and disciplines within the PALS program, the evaluators may not be experts in the specific field of the proposed project. Therefore, it is important to write the proposal accordingly, ensuring that a general expert can understand the research idea.\r\n","labels":[]},{"identifier":"SGL_call_2026","title":"SciLifeLab Group Leader Nomination form","href":"https://anubis.scilifelab.se/call/SGL_call_2026","opens":"2026-06-02T07:00:00.000Z","closes":"2026-09-01T21:59:00.000Z","description":" Nomination for SciLifeLab Group Leaders 2026\r\n\r\n- There is one (1) nomination period per year.\r\n- The nomination is for a 4-year term. The group leader status is re-evaluated every four years to ensure that the criteria continue to be met.\r\n- Nominations are submitted individually, either by a candidate directly (self-nomination) or following invitation by a SciLifeLab founding university or site committee member. Nominees are strongly encouraged to discuss their application with their respective Scientific Director/Integration Director (KI, KTH, SU, UU) or Site Directors (SciLiteLab Site Linköping, Lund, Gothenburg or Umeå), and the application should be submitted with support from the Head of Department\r\n- The applicant must provide examples on concrete contributions to SciLifeLab´s activities (not to SciLifeLab:s strategic objectives in general). Example contributions are given in the SciLifeLab\r\nGroup Leader Principles & Guidelines document (https://www.scilifelab.se/research/group-leader-definition/#h-definition.) Contributions within all five areas of SciLifeLab:s objectives are not required. \r\n\r\n- A current position as SciLifeLab or DDLS Fellow, Platform Director, Platform Co-Director, or Head of Unit automatically includes the SciLifeLab Group Leader status, and therefore these individuals do not need to be nominated if their roles or assignments are in force (re-evaluation every 4-years still applies).\r\n\r\n- Pre-screening and initial selection are conducted by SciLifeLab university and site committees.\r\n- The SciLifeLab Strategic Management group evaluate and prepare a recommendation to the SciLifeLab Board, which makes the final decision.\r\n- SciLifeLab aim for a minimum of 40% applications and approved nominations from the underrepresented gender\r\n- Approved nominations are publicly announced on the SciLifeLab website.\r\n\r\nAll SciLifeLab Group Leader data (such as publications and other contributions) will be made public if the nomination is approved, and data will be used for web profile pages. It is the responsibility of the applicants to provide exact information.\r\n\r\nIf you have any questions regarding the nomination process for SciLifeLab Group Leaders, please contact nomination@scilifelab.se. More information about the SciLifeLab Group Leader definition can be found here: https://www.scilifelab.se/research/group-leader-definition/.","labels":[]},{"identifier":"WASPDDLS26","title":"DDLS and WASP joint call for research projects 2026","href":"https://anubis.scilifelab.se/call/WASPDDLS26","opens":"2026-04-22T13:00:00.000Z","closes":"2026-09-07T12:00:00.000Z","description":"DDLS and WASP have a strong ambition to form solid collaborations by bridging the gap between the scientific disciplines of DDLS and WASP respectively. The Knut and Alice Wallenberg foundation has earmarked funding for such collaborations in their donations to both these programs. To amplify their collaboration, DDLS and WASP announce a third call for proposals for bridging research projects. More information about the call can be found [here](https://www.scilifelab.se/data-driven/wasp-collaboration/ddls-and-wasp-joint-call-for-research-projects-2026/)","labels":[]},{"identifier":"IC26","title":"Instrument call 2026 for infrastructure units","href":"https://anubis.scilifelab.se/call/IC26","opens":"2026-05-19T10:00:00.000Z","closes":"2026-09-11T21:59:00.000Z","description":"This call is open only for the infrastructure units of SciLifeLab.","labels":[]},{"identifier":"REDPROJ26","title":"RED Project call 2026","href":"https://anubis.scilifelab.se/call/REDPROJ26","opens":"2026-06-14T22:00:00.000Z","closes":"2026-09-18T21:59:00.000Z","description":"## Scope and Funding\r\nRED Project funding is intended to enable research groups at Campus Solna to explore new hypotheses, innovative biomedical ideas, and significant biological challenges. This includes the exploration of high-risk, novel technical applications that may not yet be mature enough for conventional funding. Projects should aim for proof-of-principle with a strong potential for future impact.\r\n\r\nA project grant can be used for all types of project costs, including:\r\n- Postdoc salaries (previously handled through separate fellowships).\r\n- Smaller equipment necessary for the project (previously handled through separate equipment calls).\r\n- Personnel costs, materials, consumables, and overhead (OH).\r\n\r\n**Funding Level:** Grants are typically funded at a maximum level of 1 MSEK/yr for up to 2 years. The total budget for RED projects has been increased. The ambition is to support 6 high-caliber ongoing projects.\r\n\r\n## Eligibility and Requirements\r\nOpen to SciLifeLab group leaders at Stockholm Trio (KTH, KI & SU).  \r\nApplications should preferably involve two independent research groups, at least one established and located at SciLifeLab Campus Solna, demonstrating clear scientific synergy that would not exist otherwise.\r\n\"Blue-sky\" research and high-risk, high-reward concepts are prioritized over incremental projects.\r\nPriority is given to projects with the potential to develop new technologies or methodologies for the SciLifeLab infrastructure at Campus Solna.\r\n\r\n## Evaluation Criteria\r\nApplications will be reviewed by a panel based on the following criteria:  \r\n**Scientific Excellence:** Scientific merit and the applicants' past performance.  \r\n**Collaboration Synergy:** The necessity and benefit of the multi-university partnership.  \r\n**Innovation Potential:** The degree of \"high-risk, high-reward\" technical development.  \r\n**Infrastructure Development:** Applicability to the broader SciLifeLab technical environment.  \r\n**Feasibility:** The likelihood of achieving proof-of-principle.  \r\n\r\n***Note:*** The evaluation committee is instructed to fund only projects of the absolute highest quality, even if it means not exhausting the full annual budget.\r\n\r\n## Application Process\r\nApplications must be submitted via the Anubis web portal.  \r\nRequired Components:  \r\n**Project Aims:** Brief description of aims and future potential impact (Max 1,500 characters).  \r\n**Project Plan:** Detailed description of execution, collaborative partners, and resources (Max 9,000 characters).  \r\n**Future Potential and Impact:** Explanation of how the technology can be broadly applied to biological problems (Max 1,500 characters).  \r\n**Budget:** A relevant two-year budget specifying personnel, equipment, and consumables.  \r\n\r\n## Timeline\r\n**Call Opens:** June 15, 2026.  \r\n**Submission Deadline:** September 18, 2026.  \r\n**Review Period:** September – November 2026.  \r\n**CSC Decision:** December 2, 2026.  \r\n**Project Start:** January 1, 2027.  \r\n","labels":[]},{"identifier":"WASPHSDDLS26","title":"WASP-HS and DDLS Research initiation grants for data-driven life sciences and society 2026","href":"https://anubis.scilifelab.se/call/WASPHSDDLS26","opens":"2026-04-28T10:00:00.000Z","closes":"2026-11-04T14:00:00.000Z","description":"This call aims to provide funding for research investigating the human and social challenges of data-driven strategies developed and applied within the life sciences. The research should aim to increase the understanding of how using artificial intelligence (AI), autonomous systems, and data-driven methodologies has effects and consequences in the life sciences, medicine, and/or society.\r\n","labels":[]},{"identifier":"EVENT2027","title":"Financial support for a SciLifeLab event in 2027 for SciLifeLab Infrastructure and SciLifeLab Group Leaders","href":"https://anubis.scilifelab.se/call/EVENT2027","opens":"2026-06-23T08:00:00.000Z","closes":"2026-11-11T12:00:00.000Z","description":"SciLifeLab aims to support events within the scope of our fields of research, open to participants from all over Sweden. We aim to encourage collaboration among and between SciLifeLab infrastructure and researchers, as well as with external organizations, and increase awareness of SciLifeLab to the broader research community in Sweden and abroad. A SciLifeLab infrastructure platform/unit or a SciLifeLab group leader must be the organizer or a visible co-organizer.\r\n\r\nDetailed information about the call can be found in the document [Event support 2027](https://anubis.scilifelab.se/call/EVENT2027/documents/Event%20support%202027.pdf)","labels":[]}]}